These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9236953)

  • 61. Cognitive performance on Piagetian tasks by Alzheimer's disease patients.
    Thornbury JM
    Res Nurs Health; 1992 Feb; 15(1):11-8. PubMed ID: 1579646
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Pleasant Events Schedule-AD: psychometric properties and relationship to depression and cognition in Alzheimer's disease patients.
    Logsdon RG; Teri L
    Gerontologist; 1997 Feb; 37(1):40-5. PubMed ID: 9046704
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Brief cognitive assessment of Alzheimer's disease in advanced stages: Proposal for a Brazilian version of the Short Battery for Severe Impairment (SIB-8).
    Wajman JR; Bertolucci PHF
    Dement Neuropsychol; 2013; 7(2):164-170. PubMed ID: 29213835
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of the Columbia University Scale to assess psychopathology in Alzheimer's disease.
    Devanand DP
    Int Psychogeriatr; 1997; 9 Suppl 1():137-42; discussion 143-50. PubMed ID: 9447437
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Longitudinal course of behavioral problems during Alzheimer's disease: linear versus curvilinear patterns of decline.
    McCarty HJ; Roth DL; Goode KT; Owen JE; Harrell L; Donovan K; Haley WE
    J Gerontol A Biol Sci Med Sci; 2000 Apr; 55(4):M200-6. PubMed ID: 10811149
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monitoring of general knowledge: evidence for preservation in early Alzheimer's disease.
    Bäckman L; Lipinska B
    Neuropsychologia; 1993 Apr; 31(4):335-45. PubMed ID: 8502369
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The validity of dependence as a health outcome measure in Alzheimer's disease.
    Spackman DE; Kadiyala S; Neumann PJ; Veenstra DL; Sullivan SD
    Am J Alzheimers Dis Other Demen; 2013 May; 28(3):245-52. PubMed ID: 23512996
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cranial electrostimulation (CES) in patients with probable Alzheimer's disease.
    Scherder EJ; Deijen JB; Vreeswijk SH; Sergeant JA; Swaab DF
    Behav Brain Res; 2002 Jan; 128(2):215-7. PubMed ID: 11796166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality.
    Sclan SG; Reisberg B
    Int Psychogeriatr; 1992; 4 Suppl 1():55-69. PubMed ID: 1504288
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Visual analogue scales for pain assessment in Alzheimer's disease.
    Scherder EJ; Bouma A
    Gerontology; 2000; 46(1):47-53. PubMed ID: 11111229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factorial validation of the Severe Impairment Battery for patients with Alzheimer's disease. A pilot study.
    Pélissier C; Roudier M; Boller F
    Dement Geriatr Cogn Disord; 2002; 13(2):95-100. PubMed ID: 11844891
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of outcome in clinical trials in Alzheimer's disease.
    Snowden JS
    Neuroepidemiology; 1990; 9(4):216-22. PubMed ID: 2215846
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monitoring progression in Alzheimer's disease.
    Galasko D; Corey-Bloom J; Thal LJ
    J Am Geriatr Soc; 1991 Sep; 39(9):932-41. PubMed ID: 1842209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current diagnostic methods and outcome variables for clinical investigation of Alzheimer's disease.
    Gauthier S; Panisset M
    J Neural Transm Suppl; 1998; 53():251-4. PubMed ID: 9700662
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quality of life in Alzheimer's disease.
    Howard K; Rockwood K
    Dementia; 1995; 6(2):113-6. PubMed ID: 7606279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High degree of heterogeneity in Alzheimer's disease progression patterns.
    Komarova NL; Thalhauser CJ
    PLoS Comput Biol; 2011 Nov; 7(11):e1002251. PubMed ID: 22072952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnosing and treating Alzheimer's disease: a practitioner's overview.
    Langbart C
    J Am Acad Nurse Pract; 2002 Mar; 14(3):103-9; quiz 110-2. PubMed ID: 11924332
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deterioration of spontaneous speech in AD patients during a 1-year follow-up: homogeneity of profiles and factors associated with progression.
    Romero B; Kurz A
    Dementia; 1996; 7(1):35-40. PubMed ID: 8788080
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease.
    Jutten RJ; Papp KV; Hendrix S; Ellison N; Langbaum JB; Donohue MC; Hassenstab J; Maruff P; Rentz DM; Harrison J; Cummings J; Scheltens P; Sikkes SAM
    Alzheimers Dement; 2023 Feb; 19(2):708-720. PubMed ID: 36086926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical Data Interchange Standards in Clinical Trials on Alzheimer's Disease.
    Na R; Bae JB; Jung SH; Kim KW
    Psychiatry Investig; 2022 Oct; 19(10):814-823. PubMed ID: 36327961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.